Haloteco Announces Voluntary Nationwide Recall of Libipower Plus

July 17, 2009

Earlier this week, manufacturer Haloteco (Los Angeles) announced a voluntary nationwide recall of its product Libipower Plus, according to FDA (Rockville, MD). The recall came when FDA reported finding tadalalafil in lab analysis of product samples.

Earlier this week, manufacturer Haloteco (Los Angeles) announced a voluntary nationwide recall of its product Libipower Plus, according to FDA (Rockville, MD). The recall came when FDA reported finding tadalalafil in lab analysis of product samples.

Tadalalafil is the active ingredient in FDA-approved drugs prescribed for erectile dysfunction that may cause various dangerous side effects like low blood pressure and interaction with nitrates found in certain prescription drugs.